DMK
IMMU

David M. Knott’s Immunomedics Inc IMMU Stock Holding History

David M. Knott’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-29,783
Closed -$620K – 111
2018
Q3 		$620K Sell
29,783
-2,000
-6% -$47.4K 0.2% 56
2018
Q2 		$752K Sell
31,783
-26,700
-46% -$537K 0.28% 50
2018
Q1 		$854K Hold
58,483
– – 0.35% 43
2017
Q4 		$945K Sell
58,483
-7,000
-11% -$82.6K 0.38% 34
2017
Q3 		$915K Sell
65,483
-300
-0.5% -$2.99K 0.39% 27
2017
Q2 		$581K Buy
65,783
+20,283
+45% +$142K 0.24% 47
2017
Q1 		$294K Buy
+45,500
New +$231K 0.14% 43

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

David M. Knott's IMMU Position: Q4 2018 in Review

David M. Knott sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 29,783 shares — an estimated $620K sold.

David M. Knott first reported a position in IMMU in Q1 2017 and held it in 7 quarters. The position peaked at $945K in Q4 2017. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • David M. Knott reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • David M. Knott sold 29,783 Immunomedics Inc shares in Q4 2018, an estimated $620K.
  • David M. Knott first reported a position in Immunomedics Inc in Q1 2017 and held it in 7 quarters.
  • David M. Knott's Immunomedics Inc position peaked at $945K in Q4 2017.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on David M. Knott's 13F filing for Q4 2018, filed 12 Feb 2019.